Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
17 authors.
Rosa PelloDepartment of Clinical Biochemistry and Laboratory Medicine, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.ORCID 0009-0004-6894-2755
María Ángeles IglesiasDepartment of Clinical Biochemistry and Laboratory Medicine, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.ORCID 0009-0006-7517-4576
Raúl VidalDepartment of Clinical Biochemistry and Laboratory Medicine, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.ORCID 0000-0002-2424-3301
Raúl MateosDepartment of Clinical Biochemistry and Laboratory Medicine, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Marta OutónDepartment of Clinical Biochemistry and Laboratory Medicine, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.ORCID 0009-0006-5796-4638
Cristina AgullóDepartment of Clinical Biochemistry and Laboratory Medicine, Hospital Universitario de Salamanca, 37007 Salamanca, Spain.
Nerea VaroDepartment of Clinical Biochemistry and Laboratory Medicine, Clínica Universidad de Navarra, 31008 Navarra, Spain.ORCID 0000-0002-2362-9472
Alberto Blanco-SánchezDepartment of Hematology and Hemotherapy, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Nieves López-MuñozDepartment of Hematology and Hemotherapy, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Álvaro GarcíaDepartment of Hematology and Hemotherapy, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Fátima MirasDepartment of Hematology and Hemotherapy, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Rodrigo IñiguezDepartment of Hematology and Hemotherapy, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.ORCID 0000-0002-2804-5038
Daniel Gil-AlósDepartment of Hematology and Hemotherapy, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.ORCID 0009-0002-8504-2842
Rafael AlonsoDepartment of Hematology and Hemotherapy, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Elena Ana LópezDepartment of Clinical Biochemistry and Laboratory Medicine, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Joaquín Martínez-LópezDepartment of Hematology and Hemotherapy, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
María Teresa CedenaDepartment of Hematology and Hemotherapy, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.ORCID 0000-0001-5851-3720
Funding
This project was partially funded by the CRIS Foundation (project 2023/001). (project 2023/001)
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Mass Spectrometry Profiling of Therapeutic Antibodies in Multiple Myeloma: · full record | OpenQuestion